{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:01:34Z","timestamp":1778846494985,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1124\/dmd.117.079467","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T18:50:21Z","timestamp":1520621421000},"page":"697-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["MRP2 Inhibition by HIV Protease Inhibitors in Rat and Human Hepatocytes: A Quantitative Confocal Microscopy Study"],"prefix":"10.1016","volume":"46","author":[{"given":"Nico","family":"Holmstock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies","family":"Oorts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Snoeys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-7351","authenticated-orcid":false,"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.117.079467_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2007.02.036","article-title":"Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor","volume":"339","author":"Agarwal","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.117.079467_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00498250903509375","article-title":"Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1","volume":"40","author":"Annaert","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.117.079467_bib3","first-page":"1277","article-title":"P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes","volume":"29","author":"Annaert","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079467_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/dmd.114.062034","article-title":"Meta-analysis of expression of hepatic organic anion-transporting polypeptide (OATP) transporters in cellular systems relative to human liver tissue","volume":"43","author":"Bad\u00e9e","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079467_bib5","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/jac\/dkq209","article-title":"Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines","volume":"65","author":"Bierman","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/dmd.117.079467_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/dmd.107.018200","article-title":"Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes","volume":"36","author":"Bow","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079467_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/17425255.2013.773973","article-title":"Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity","volume":"9","author":"De Bruyn","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.117.079467_bib8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/jps.24564","article-title":"Clearance prediction of HIV protease inhibitors in man: role of hepatic uptake","volume":"105","author":"De Bruyn","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.079467_bib9","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.tiv.2014.05.010","article-title":"Quantification of biliary excretion and sinusoidal excretion of 5(6)-carboxy-2\u2032,7\u2032-dichlorofluorescein (CDF) in cultured hepatocytes isolated from Sprague Dawley, Wistar and Mrp2-deficient Wistar (TR(-)) rats","volume":"28","author":"Ellis","year":"2014","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.117.079467_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejpb.2007.10.003","article-title":"Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system","volume":"69","author":"F\u00f6rster","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/dmd.117.079467_bib11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1124\/dmd.104.000372","article-title":"Estradiol 3-glucuronide is transported by the multidrug resistance-associated protein 2 but does not activate the allosteric site bound by estradiol 17-glucuronide","volume":"32","author":"Gerk","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079467_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.117.079467_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/jpet.104.065342","article-title":"HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP\/ABCG2)","volume":"310","author":"Gupta","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.079467_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0026-895X(24)12649-1","article-title":"Interactions of HIV protease inhibitors with ATP-dependent drug export proteins","volume":"56","author":"Gutmann","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.117.079467_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1124\/mol.114.092262","article-title":"Differential effects of membrane cholesterol content on the transport activity of multidrug resistance-associated protein 2 (ABCC2) and of the bile salt export pump (ABCB11)","volume":"85","author":"Guyot","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.117.079467_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1087057108316702","article-title":"Characterization of 5(6)-carboxy-2,\u20187\u2019-dichlorofluorescein transport by MRP2 and utilization of this substrate as a fluorescent surrogate for LTC4","volume":"13","author":"Heredi-Szabo","year":"2008","journal-title":"J Biomol Screen"},{"key":"10.1124\/dmd.117.079467_bib17","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200211220-00009","article-title":"Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs","volume":"16","author":"Huisman","year":"2002","journal-title":"AIDS"},{"key":"10.1124\/dmd.117.079467_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3851\/IMP1399","article-title":"P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir","volume":"14","author":"Janneh","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1124\/dmd.117.079467_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/bjp.2008.320","article-title":"Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir","volume":"155","author":"Janneh","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.117.079467_bib20","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00002030-200107270-00004","article-title":"P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?","volume":"15","author":"Jones","year":"2001","journal-title":"AIDS"},{"key":"10.1124\/dmd.117.079467_bib21","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/jps.24477","article-title":"Unbound ritonavir concentrations in rat and human hepatocytes","volume":"104","author":"Keemink","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.079467_bib22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/clpt.2012.79","article-title":"A perspective on efflux transport proteins in the liver","volume":"92","author":"K\u00f6ck","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.117.079467_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0005-2736(99)00169-8","article-title":"Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance","volume":"1461","author":"K\u00f6nig","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.117.079467_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejpb.2010.03.008","article-title":"Development of a fluorescence-based assay for drug interactions with human Multidrug Resistance Related Protein (MRP2; ABCC2) in MDCKII-MRP2 membrane vesicles","volume":"75","author":"Lechner","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/dmd.117.079467_bib25","doi-asserted-by":"crossref","first-page":"C1764","DOI":"10.1152\/ajpcell.1994.266.6.C1764","article-title":"Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration","volume":"266","author":"LeCluyse","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.117.079467_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0887-2333(99)00096-X","article-title":"Regeneration and maintenance of bile canalicular networks in collagen-sandwiched hepatocytes","volume":"14","author":"LeCluyse","year":"2000","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.117.079467_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1124\/dmd.108.023234","article-title":"Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2\/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human","volume":"37","author":"Li","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079467_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bdd.1832","article-title":"Interaction between HIV protease inhibitors (PIs) and hepatic transporters in sandwich cultured human hepatocytes: implication for PI-based DDIs","volume":"34","author":"Liu","year":"2013","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.117.079467_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/dmd.113.054528","article-title":"Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition","volume":"42","author":"Lundquist","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079467_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/toxsci\/kfs167","article-title":"Human and rat ABC transporter efflux of bisphenol a and bisphenol a glucuronide: interspecies comparison and implications for pharmacokinetic assessment","volume":"128","author":"Mazur","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.117.079467_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"Morgan","year":"2013","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.117.079467_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.taap.2012.06.016","article-title":"Application of quantitative time-lapse imaging (QTLI) for evaluation of Mrp2-based drug-drug interaction induced by liver metabolites","volume":"263","author":"Nakanishi","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.117.079467_bib33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1124\/dmd.111.038059","article-title":"Quantitative time-lapse imaging-based analysis of drug-drug interaction mediated by hepatobiliary transporter, multidrug resistance-associated protein 2, in sandwich-cultured rat hepatocytes","volume":"39","author":"Nakanishi","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079467_bib34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/dmd.115.068114","article-title":"Transport-metabolism interplay of atazanavir in rat hepatocytes","volume":"44","author":"Nicola\u00ef","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079467_bib35","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00204-015-1575-9","article-title":"Bile canalicular dynamics in hepatocyte sandwich cultures","volume":"89","author":"Reif","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.117.079467_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00002030-200103090-00007","article-title":"Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier","volume":"15","author":"van der Sandt","year":"2001","journal-title":"AIDS"},{"key":"10.1124\/dmd.117.079467_bib37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.106.012765","article-title":"Inhibition of MRP1\/ABCC1, MRP2\/ABCC2, and MRP3\/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors","volume":"35","author":"Weiss","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079467_bib38","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1016\/j.bmc.2015.04.029","article-title":"Exploring the structure-activity relationships of ABCC2 modulators using a screening approach","volume":"23","author":"Wissel","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/dmd.117.079467_bib39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/bdd.701","article-title":"Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytes","volume":"31","author":"Ye","year":"2010","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.117.079467_bib40","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.102.044107","article-title":"Pharmacokinetics of 5 (and 6)-carboxy-2\u2032,7\u2032-dichlorofluorescein and its diacetate promoiety in the liver","volume":"304","author":"Zamek-Gliszczynski","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.079467_bib41","doi-asserted-by":"crossref","first-page":"23538","DOI":"10.1074\/jbc.M303504200","article-title":"Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2)","volume":"278","author":"Zelcer","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.117.079467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:35:17Z","timestamp":1739903717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624055168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0090955624055168"],"URL":"https:\/\/doi.org\/10.1124\/dmd.117.079467","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRP2 Inhibition by HIV Protease Inhibitors in Rat and Human Hepatocytes: A Quantitative Confocal Microscopy Study","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.117.079467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}